Single dose regorafenib-induced hypertensive crisis
Gastrointestinal stromal tumors (GISTs) are uncommon tumors of the gastrointestinal (GI) tract. Regorafenib is a new multikinase inhibitor and is approved for the treatment of GISTs in patients who develop resistance to imatinib and sunitinib. The most common drug-related adverse events with regoraf...
Saved in:
| Date: | 2014 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2014
|
| Series: | Experimental Oncology |
| Subjects: | |
| Online Access: | http://dspace.nbuv.gov.ua/handle/123456789/145356 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Single dose regorafenib-induced hypertensive crisis / B. Yilmaz, Y. Kemal, F. Teker, E. Kut, G. Demirag, I. Yucel // Experimental Oncology. — 2014. — Т. 36, № 2. — С. 134-135. — Бібліогр.: 15 назв. — англ. |